date/time interval
- July 15, 2022 - June 30, 2025
Phase II randomized controlled trial of benfotiamine in early Alzheimer''s Disease
Grant
Overview
awarded by
administered by
sponsor award ID
- 1 R01 AG076634-01
Affiliation
contributor
- Nordvig, Anna Starikovsky Principal Investigator (Subaward) 2022 - 2024